- Home
- VKTX vs BIPC Comparison
VKTX vs BIPC Comparison
Compare VKTX & BIPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VKTX | BIPC |
|---|---|---|
| Founded | 2012 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.8B |
| IPO Year | 2014 | 2019 |
Fundamental Metrics
Financial Performance| Metric | VKTX | BIPC |
|---|---|---|
| Price | $34.85 | $41.61 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 7 | 1 |
| Target Price | ★ $95.86 | $45.00 |
| AVG Volume (30 Days) | ★ 2.4M | 832.1K |
| Earning Date | 04-29-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 5.13% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $7.85 |
| Revenue Next Year | N/A | $5.94 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.96 | $34.18 |
| 52 Week High | $43.15 | $51.72 |
Technical Indicators
Market Signals| Indicator | VKTX | BIPC |
|---|---|---|
| Relative Strength Index (RSI) | 44.70 | 63.76 |
| Support Level | $34.03 | $37.42 |
| Resistance Level | $36.77 | $42.84 |
| Average True Range (ATR) | 2.05 | 0.81 |
| MACD | -0.66 | 0.27 |
| Stochastic Oscillator | 3.75 | 79.95 |
Price Performance
Historical ComparisonAbout VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About BIPC Brookfield Infrastructure Corporation
Brookfield Infrastructure Corp is an indirect subsidiary of the partnership of the diversified infrastructure owner and operators. Its business is comprised of a U.K. regulated distribution operation, a Brazilian regulated natural gas transmission operation and an international intermodal logistics operation. Geographically, the company generates a majority of its revenue from Brazil and rest from United Kingdom, United States, France, Switzerland, Singapore, China, Denmark, Hong Kong, Germany and Others.